Cortes Ballen A, Amosu M, Ravinder S, Chan J, Derin E, Slika H
Cells. 2024; 13(18.
PMID: 39329757
PMC: 11430559.
DOI: 10.3390/cells13181574.
Rullo R, Cerchia C, Nasso R, Romanelli V, De Vendittis E, Masullo M
Antioxidants (Basel). 2023; 12(4).
PMID: 37107199
PMC: 10135315.
DOI: 10.3390/antiox12040825.
Costas-Ferreira C, Faro L
Int J Mol Sci. 2021; 22(16).
PMID: 34445117
PMC: 8395098.
DOI: 10.3390/ijms22168413.
Jonsson P, Antti H, Spath F, Melin B, Bjorkblom B
Cancers (Basel). 2020; 12(11).
PMID: 33198241
PMC: 7696703.
DOI: 10.3390/cancers12113349.
Peleli M, Moustakas A, Papapetropoulos A
Int J Mol Sci. 2020; 21(19).
PMID: 33036204
PMC: 7582718.
DOI: 10.3390/ijms21197371.
Xanthine Oxidase/Dehydrogenase Activity as a Source of Oxidative Stress in Prostate Cancer Tissue.
Veljkovic A, Hadzi-dokic J, Sokolovic D, Basic D, Velickovic-Jankovic L, Stojanovic M
Diagnostics (Basel). 2020; 10(9).
PMID: 32899343
PMC: 7555171.
DOI: 10.3390/diagnostics10090668.
ROS Generation and Antioxidant Defense Systems in Normal and Malignant Cells.
Snezhkina A, Kudryavtseva A, Kardymon O, Savvateeva M, Melnikova N, Krasnov G
Oxid Med Cell Longev. 2019; 2019:6175804.
PMID: 31467634
PMC: 6701375.
DOI: 10.1155/2019/6175804.
Metabolomic screening of pre-diagnostic serum samples identifies association between α- and γ-tocopherols and glioblastoma risk.
Bjorkblom B, Wibom C, Jonsson P, Moren L, Andersson U, Johannesen T
Oncotarget. 2016; 7(24):37043-37053.
PMID: 27175595
PMC: 5095057.
DOI: 10.18632/oncotarget.9242.
Xanthine oxidoreductase in cancer: more than a differentiation marker.
Battelli M, Polito L, Bortolotti M, Bolognesi A
Cancer Med. 2015; 5(3):546-57.
PMID: 26687331
PMC: 4799950.
DOI: 10.1002/cam4.601.
1'-Acetoxychavicol acetate promotes caspase 3-activated glioblastoma cell death by overcoming enhanced cytokine expression.
Williams M, Tietzel I, Quick Q
Oncol Lett. 2013; 5(6):1968-1972.
PMID: 23833677
PMC: 3700938.
DOI: 10.3892/ol.2013.1292.
Levels of certain tumor markers as differential factors between bilharzial and non-biharzial bladder cancer among Egyptian patients.
Metwally N, Ali S, Mohamed A, Khaled H, Ahmed S
Cancer Cell Int. 2011; 11(1):8.
PMID: 21473769
PMC: 3097143.
DOI: 10.1186/1475-2867-11-8.
Preferential inhibition of xanthine oxidase by 2-amino-6-hydroxy-8-mercaptopurine and 2-amino-6-purine thiol.
Kalra S, Jena G, Tikoo K, Mukhopadhyay A
BMC Biochem. 2007; 8:8.
PMID: 17511860
PMC: 1885804.
DOI: 10.1186/1471-2091-8-8.
Lipid peroxidation and activity of some antioxidant enzymes in patients with glioblastoma and astrocytoma.
Wozniak B, Wozniak A, Kasprzak H, Drewa G, Mila-Kierzenkowska C, Drewa T
J Neurooncol. 2006; 81(1):21-6.
PMID: 16773213
DOI: 10.1007/s11060-006-9202-5.
Chemoprevention of azoxymethane-induced rat colon carcinogenesis by a xanthine oxidase inhibitor, 1'-acetoxychavicol acetate.
Tanaka T, Kawabata K, Kakumoto M, Makita H, Matsunaga K, Mori H
Jpn J Cancer Res. 1997; 88(9):821-30.
PMID: 9369929
PMC: 5921523.
DOI: 10.1111/j.1349-7006.1997.tb00457.x.
Wine as a biological fluid: history, production, and role in disease prevention.
Soleas G, Diamandis E, Goldberg D
J Clin Lab Anal. 1997; 11(5):287-313.
PMID: 9292395
PMC: 6760744.
Chemopreventive effect of a xanthine oxidase inhibitor, 1'-acetoxychavicol acetate, on rat oral carcinogenesis.
Ohnishi M, Tanaka T, Makita H, Kawamori T, Mori H, Satoh K
Jpn J Cancer Res. 1996; 87(4):349-56.
PMID: 8641965
PMC: 5921100.
DOI: 10.1111/j.1349-7006.1996.tb00229.x.
Levels of water-soluble antioxidants in astrocytoma and in adjacent tumor-free tissue.
Landolt H, LANGEMANN H, Probst A, Gratzl O
J Neurooncol. 1994; 21(2):127-33.
PMID: 7861188
DOI: 10.1007/BF01052896.
